A role for reduced coenzyme Q in atherosclerosis?

BioFactors

Volumn 9, Issue 2-4, 1999, Pages 207-224

  Thomas, Shane R ^a   Witting, Paul K ^a   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; HYDROQUINONE DERIVATIVE; LOW DENSITY LIPOPROTEIN; OXIDIZING AGENT; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; HUMAN; INTIMA; KNOCKOUT MOUSE; LIPID PEROXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033038638     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520090216     Document Type: Article

References (113)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum, Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity, New Engl. J. Med. 320 (1989), 915-924.
2. J.A. Berliner and J.W. Heinecke, The role of oxidized lipoproteins in atherogenesis, Free Radic. Biol. Med. 20 (1996), 707-727.
3. A. Daugherty, J.L. Dunn, D.L. Rateri and J.W. Heinecke, Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions, J. Clin. Invest. 94 (1994), 437-444.
4. C. Leeuwenburgh, J.E. Rasmussen, F.F. Hsu, D.M. Mueller, S. Pennathur and J.W. Heinecke, Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques, J. Biol. Chem. 272 (1997), 3520-3526.
5. L.J. Hazell, L. Arnold, D. Flowers, G. Waeg, E. Malle and R. Stocker, Presence of hypochlorite-modified proteins in human atherosclerotic lesions, J. Clin. Invest. 97 (1996), 1535-1544.
6. J.S. Beckman, Y.Z. Ye, P.G. Anderson, J. Chen, M.A. Accavitti, M.M. Tarpey and C.R. White, Extensive nitration of protein tyrosine in human atherosclerosis detected by immunohistochemistry, Biol. Chem. Hoppe Seyler. 375 (1994), 81-88.
7. C. Leeuwenburgh, M.M. Hardy, S.L. Hazen, P. Wagner, S. Oh-ishi, U.P. Steinbrecher and J.W. Heinecke, Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima, J. Biol. Chem. 272 (1997), 1433-1436.
8. J.S. Luoma, P. Strålin, S.L. Marklund, T.P. Hiltunen, T. Sarkioja and S. Ylä-Herttuala, Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins, Arterioscler. Thromb. Vasc. Biol. 18 (1998), 157-167.
9. S. Fu, M.J. Davies, R. Stocker and R.T. Dean, Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque, Biochem. J. 333 (1998), 519-525.
10. H. Kühn, D. Heydeck, I. Hogou and C. Gniwotta, In vivo action of 15-lipoxygenase in early stages of human atherogenesis, J. Clin. Invest. 99 (1997), 888-893.
11. J. Shen, E. Herderick, J.F. Cornhill, E. Zsigmond, H.-S. Kim, H. Kühn, N.V. Guevara and L. Chan, Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development, J. Clin. Invest. 98 (1996), 2201-2208.
12. D.J. Lamb, M.J. Mitchinson and D.S. Leake, Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages, FEBS Lett. 374 (1995), 12-16.
13. J.L. Witztum, Susceptibility of low-density lipoprotein to oxidative modification, Am. J. Med. 94 (1993), 347-349.
14. E.B. Rimm and M.J. Stampfer, The role of antioxidants in preventive cardiology, Curr. Opin. Cardiol. 12 (1997), 188-194.
15. R.K. Tangirala, F. Casanada, E. Miller, J.L. Witztum, D. Steinberg and W. Palinski, Effect of the antioxidant N,N′-diphenyl-1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice, J. Lipid Res. 15 (1995), 1625-1630.
16. O. Cynshi, Y. Kawabe, T. Suzuki, Y. Takashima, H. Kaise, M. Nakamura, Y. Ohba, Y. Kato, K. Tamura, A. Hayasaka, A. Higashida, H. Sakaguchi, M. Takeya, K. Takahashi, K. Inoue, N. Noguchi, E. Niki and T. Kodama, Antiatherogenic effects of the antioxidant BO-653 in three different animal models, Proc. Natl. Acad. Sci. USA 95 (1998), 10 123-10 128.
17. P.K. Witting, K. Pettersson, A.-M. Östlund-Lindqvist, C. Westerlund, A. Westin Eriksson and R. Stocker, Inhibition by a co-antioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice, FASEB J. 13 (1999), 667-675.
18. T.E. Carew, D.C. Schwenke and D. Steinberg, Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, Proc. Natl. Acad. Sci. USA 84 (1987), 7725-7729.
19. I. Björkhem, A. Henriksson-Freyschuss, O. Breuer, U. Diczfalusy, L. Berglund and P. Henriksson, The antioxidant butylated hydroxytoluene protects against atherosclerosis, Arterioscler. Thromb. 11 (1991), 15-22.
20. S.J. Mao, M.T. Yates, A.E. Rechtin, R.L. Jackson and A. Van-Sickle, Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits, J. Med. Chem. 34 (1991), 298-302.
21. C.P. Sparrow, T.W. Doebber, J. Olszewski, M.S. Wu, J. Ventre, K.A. Stevens and Y.S. Chao, Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine, J. Clin. Invest. 89 (1992), 1885-1891.
22. M. Sasahara, E.W. Raines, A. Chait, T.E. Carew, D. Steinberg, P.W. Wahl and R. Ross, Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?, J. Clin. Invest. 94 (1994), 155-164.
23. J. Fruebis, D. Steinberg, H.A. Dresel and T.A. Carew, A comparison of the antiatherogenic effects of probucol and a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits, J. Clin. Invest. 94 (1994), 392-398.
24. H. Esterbauer, J. Gebicki, H. Puhl and G. Jürgens, The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free Radic. Biol. Med. 13 (1992), 341-390.
25. J. Fruebis, D.A. Bird, J. Pattison and W. Palinski, Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants, J. Lipid Res. 38 (1997), 2455-2464.
26. S.H. Zhang, R.L. Reddick, E. Avdievich, L.K. Surles, R.G. Jones, J.B. Reynolds, S.H. Quarfordt and N. Maeda, Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice, J. Clin. Invest. 99 (1997), 2858-2866.
27. S.L. Godfried, G.F. Combs, J.M. Saroka and L.A. Dillingham, Potentiation of atherosclerotic lesions in rabbits by high dietary level of vitamin E, Br. J. Nutr. 61 (1989), 607-617.
28. J.F. Keaney, Jr., J.M. Gaziano, A. Xu, B. Frei, J. Curran-Celentano, G.T. Shwaery, J. Loscalzo and J.A. Vita, Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits, J. Clin. Invest. 93 (1994), 844-851.
29. D. Pratico, R.K. Tangirala, D. Radar, J. Rokach and G.A. FitzGerald, Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice, Nature Med. 4 (1998), 1189-1192.
30. J. Sun, D.W. Giraud, R.A. Moxley and J.A. Driskell, b-Carotene and alpha-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits, Int. J. Vitam. Nutr. Res. 67 (1997), 155-163.
31. Y. Qiao, M. Yokoyama, K. Kameyama and G. Asano, Effect of vitamin E on vascular integrity in cholesterol-fed guinea pigs, Arterioscler. Thromb. 13 (1993), 1885-1892.
32. H.A. Kleinveld, P.N. Demacker and A.F. Stalenhoef, Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits, Arterioscler. Thromb. 14 (1994), 1386-1391.
33. H.A. Kleinveld, H.L. Hak-Lemmers, M.P. Hectors, N.J. de Fouw, P.N. Demacker and A.F. Stalenhoef, Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits, Arterioscler. Thromb. Vasc. Biol. 15 (1995), 290-297.
34. J. Fruebis, T.E. Carew and W. Palinski, Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits, Atherosclerosis 117 (1995), 217-224.
35. R.B. Wilson, C.C. Middleton and G.Y. Sun, Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits, J. Nutr. 108 (1978), 1858-1867.
36. J. Wójcicki, L. Rózewicka, B. Barcew-Wiszniewska, L. Samochowiec, S. Juzwiak, D. Kadlubowska, S. Tustanowski and Z. Juzyszyn, Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits, Atherosclerosis 87 (1991), 9-16.
37. R.J. Williams, J.M. Motteram, C.H. Sharp and P.J. Gallagher, Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits, Atherosclerosis 94 (1992), 153-159.
38. A.L. Akeson, C.W. Woods, L.B. Mosher, C.E. Thomas and R.L. Jackson, Inhibition of IL-1b expression in THP-1 cells by probucol and tocopherol, Atherosclerosis 86 (1991), 261-270.
39. D. Boscoboinik, A. Szewczyk, C. Hensey and A. Azzi, Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C, J. Biol. Chem. 266 (1991), 6188-6194.
40. A. Tasinato, D. Boscoboinik, G.M. Bartoli, P. Maroni and A. Azzi, d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties, Proc. Natl. Acad. Sci. USA 92 (1995), 12 190-12 194.
41. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor, EMBO J. 12 (1993), 2005-2015.
42. R. Schreck, K. Albermann and P.A. Baeuerle, Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review), Free Rad. Res. Comms. 17 (1992), 221-237.
43. K. Brand, S. Page, G. Rogler, A. Bartsch, R. Brandl, R. Knuechel, M. Page, C. Kaltschmidt, P.A. Baeuerle and D. Neumeier, Activated transcription nuclear factor-kappa B is present in atherosclerotic lesion, J. Clin. Invest. 97 (1996), 1715-1722.
44. F. Liao, A. Andalibi, J.H. Qiao, H. Allayee, A.M. Fogelman and A.J. Lusis, Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice, J. Clin. Invest. 94 (1994), 877-884.
45. G.W. Burton and K.U. Ingold, Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function, Acc. Chem. Res. 19 (1986), 194-201.
46. V.W. Bowry and R. Stocker, Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein, J. Am. Chem. Soc. 115 (1993), 6029-6044.
47. J. Neuzil, S.R. Thomas and R. Stocker, Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation, Free Radic. Biol. Med. 22 (1997), 57-71.
48. B. Frei, R. Stocker and B.N. Ames, Antioxidant defenses and lipid peroxidation in human blood plasma, Proc. Natl. Acad. Sci. USA 85 (1988), 9748-9752.
49. R. Stocker, V.W. Bowry and B. Frei, Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol, Proc. Natl. Acad. Sci. USA 88 (1991), 1646-1650.
50. H.A. Kleinveld, A.H.J. Naber, A.F.H. Stalenhoef and P.N.M. Demacker, Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects, Free Radic. Biol. Med. 15 (1993), 273-280.
51. M. Maiorino, A. Zamburlini, A. Roveri and F. Ursini, Copper-induced lipid peroxidation in liposomes, micelles, and LDL: which is the role of vitamin E?, Free Radic. Biol. Med. 18 (1995), 67-74.
52. P.K. Witting, V.W. Bowry and R. Stocker, Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL): a simple test for tocopherol-mediated peroxidation of LDL lipids, FEBS Lett. 375 (1995), 45-49.
53. V.W. Bowry, D. Mohr, J. Cleary and R. Stocker, Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein, J. Biol. Chem. 270 (1995), 5756-5763.
54. A. Kontush, B. Finckh, B. Karten, A. Kohlschütter and U. Beisiegel, Antioxidant and prooxidant activity of α-tocopherol in human plasma and low density lipoprotein, J. Lipid Res. 37 (1996), 1436-1448.
55. S.R. Thomas, J. Neuzil and R. Stocker, Co-supplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation, Arterioscler. Thromb. Vasc. Biol. 16 (1996), 687-696.
56. K.U. Ingold, V.W. Bowry, R. Stocker and C. Walling, Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids. The unrecognized consequences of lipid particle size as exemplified by the oxidation of human low density lipoprotein, Proc. Natl. Acad. Sci. USA 90 (1993), 45-49.
57. A.R. Waldeck and R. Stocker, Radical-initiated lipid peroxidation in low density lipoproteins: insights obtained from kinetic modeling, Chem. Res. Toxicol. 9 (1996), 954-964.
58. L.R.C. Barclay, 1992 Syntex Award Lecture. Model biomembranes: quantitative studies of peroxidation, antioxidant action, partitioning, and oxidative stress, Can. J. Chem. 71 (1993), 1-16.
59. N.A. Porter, S.E. Caldwell and K.A. Mills, Mechanisms of free radical oxidation of unsaturated lipids, Lipids 30 (1995), 277-290.
60. H. Esterbauer, G. Striegl, H. Puhl and M. Rotheneder, Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Comms. 6 (1989), 67-75.
61. H. Esterbauer, M. Dieber-Rotheneder, G. Striegl and G. Waeg, Role of vitamin E in preventing the oxidation of low-density lipoprotein, Am. J. Clin. Nutr. 53 (1991), 314S-321S.
62. I. Jialal and S.M. Grundy, Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein, J. Lipid Res. 33 (1992), 899-906.
63. P.D. Reaven, A. Khouw, W.F. Beltz, S. Parthasarathy and J.L. Witztum, Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene, Arterioscler. Thromb. 13 (1993), 590-600.
64. W. Jessup, S.M. Rankin, C.V. De Whalley, J.R.S. Hoult, J. Scott and D.S. Leake, α-Tocopherol consumption during low-density lipoprotein oxidation, Biochem. J. 265 (1990), 399-405.
65. B. Frei and J.M. Gaziano, Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation, J. Lipid Res. 34 (1993), 2135-2145.
66. A. Kontush, C. Hübner, B. Finckh, A. Kohlschütter and U. Beisiegel, Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content, FEBS Lett. 341 (1994), 69-73.
67. M. Dieber-Rotheneder, H. Puhl, G. Waeg, G. Striegl and H. Esterbauer, Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation, J. Lipid Res. 32 (1991), 1325-1332.
68. V.W. Bowry, K.U. Ingold and R. Stocker, Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant, Biochem. J. 288 (1992), 341-344.
69. S. R. Thomas, M.J. Davies and R. Stocker, Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite, Chem. Res. Toxicol. 11 (1998), 484-494.
70. K.U. Ingold and J.A. Howard, Reaction of phenols with peroxy radicals, Nature 195 (1962), 280-281.
71. G.W. Burton and K.U. Ingold, Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro, J. Am. Chem. Soc. 103 (1981), 6472-6477.
72. R.H. Bisby and A.W. Parker, Reactions of the alpha-tocopheroxyl radical in micellar solutions studied by nanosecond laser flash photolysis, FEBS Lett. 290 (1991), 205-208.
73. J.B. Massey, Kinetics of transfer of α-tocopherol between model and native plasma lipoproteins, Biochim. Biophys. Acta 793 (1984), 387-392.
74. K. Mukai and Y. Okauchi, Kinetic study of the reaction between tocopheroxyl radical and unsaturated fatty acid esters in benzene, Lipids 24 (1989), 936-939.
75. S. Nagaoka, Y. Okauchi, S. Urano, U. Nagashima and K. Mukai, Kinetic and ab initio study of the prooxidant effect of vitamin E. Hydrogen abstraction from fatty acid esters and egg yolk lecithin, J. Am. Chem. Soc. 112 (1990), 8921-8924.
76. J.M. Upston, J. Neuzil and R. Stocker, Oxidation of LDL by recombinant human 15-lipoxygenase: evidence for α-tocopherol dependent oxidation of esterified core and surface lipids, J. Lipid Res. 37 (1996), 2650-2661.
77. P.K. Witting, J.M. Upston and R. Stocker, The molecular action of α-tocopherol in lipoprotein lipid peroxidation: proand antioxidant activity of vitamin E in complex heterogeneous lipid emulsions, in: Subcellular Biochemistry: Fat-Soluble Vitamins, P. Quinn and V. Kagan, eds, Plenum, London, 1998, pp. 345-390.
78. L.J. Hazell and R. Stocker, Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages, Biochem. J. 290 (1993), 165-172.
79. C.L. Hawkins and M.J. Davies, Hypochlorite-induced damage to proteins: formation of nitrogen-centered radicals from lysine residues and their role in protein fragmentation, Biochem. J. (in press).
80. R. Stocker, Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance, Curr. Opin. Lipidol. 5 (1994), 422-433.
81. T. Doba, G.W. Burton and K.U. Ingold, Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes, Biochim. Biophys. Acta 835 (1985), 298-303.
82. S.R. Thomas, J. Neuzil, D. Mohr and R. Stocker, Co-antioxidants make α-tocopherol an efficient antioxidant for LDL, Am. J. Clin. Nutr. 62 (1995), 1357S-1364S.
83. J. Neuzil and R. Stocker, Free and albumin-bound bilirubin is an efficient co-antioxidant for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation, J. Biol. Chem. 269 (1994), 16 712-16 719.
84. S.R. Thomas, P.K. Witting and R. Stocker, 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for α-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation, J. Biol. Chem. 271 (1996), 32 714-32 721.
85. P.K. Witting, C. Westerlund and R. Stocker, A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids, J. Lipid Res. 37 (1996), 853-867.
86. K. Sato, E. Niki and H. Shimasaki, Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C, Arch. Biochem. Biophys. 279 (1990), 402-405.
87. J. Neuzil and R. Stocker, Bilirubin attenuates radical-mediated damage to serum albumin, FEBS Lett. 331 (1993), 281-284.
88. J. Neuzil, P.K. Witting and R. Stocker, α-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low-density lipoprotein lipids, Proc. Natl. Acad. Sci. USA 94 (1997), 7885-7890.
89. S. Christen, S.R. Thomas, B. Garner and R. Stocker, Inhibition by interferon-γ of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway, J. Clin. Invest. 93 (1994), 2149-2158.
90. W. Jessup, D. Mohr, S.P. Gieseg, R.T. Dean and R. Stocker, The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein, Biochim. Biophys. Acta 1180 (1992), 73-82.
91. J.R. Wagner, P.A. Motchnik, R. Stocker, H. Sies and B.N. Ames, The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen, J. Biol. Chem. 268 (1993), 18502-18506.
92. D. Mohr, V.W. Bowry and R. Stocker, Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation, Biochim. Biophys. Acta 1126 (1992), 247-254.
93. J.M. Upston, J. Neuzil, P.K. Witting, R. Alleva and R. Stocker, 15-Lipoxygenase-induced enzymic oxidation of low density lipoprotein associated free fatty acids stimulates nonenzymic, α-tocopherol-mediated peroxidation of cholesteryl esters, J. Biol. Chem. 272 (1997), 30 067-30 074.
94. S. Yamashita and Y. Yamamoto, Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress, Anal. Biochem. 250 (1997), 66-73.
95. R. Stocker and C. Suarna, Extracellular reduction of ubiquinone-1 and -10 by human Hep G2 and blood cells, Biochim. Biophys. Acta 1158 (1993), 15-22.
96. V.A. Roginsky, D. Mohr and R. Stocker, Reduction of ubiquinone-1 by ascorbic acid is a catalytic and reversible process controlled by the concentration of molecular oxygen, Redox Report 2 (1996), 55-62.
97. D. Mohr, Y. Umeda, T.G. Redgrave and R. Stocker, Antioxidant defenses in rat intestine and mesenteric lymph, Redox Report (1998) (in press).
98. D.L. Tribble, J.J.M. van den Berg, P.A. Motchnik, B.N. Ames, D.M. Lewis, A. Chait and R.M. Krauss, Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content, Proc. Natl. Acad. Sci. USA 91 (1994), 1183-1187.
99. J. Kaikkonen, K. Nyyssonen, E. PorkkalaSarataho, H.E. Poulsen, T. MetsaKetela, M. Hayn, R. Salonen and J.T. Salonen, Effect of oral coenzyme Q10 supplementation on the oxidation resistance of human VLDL + LDL fraction: absorption and antioxidative properties of oil and granule-based preparations, Free Radic. Biol. Med. 22 (1997), 1195-1202.
100. W. Sattler, D. Mohr and R. Stocker, Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence, Methods Enzymol. 233 (1994), 469-489.
101. K. Mukai, S. Itoh and H. Morimoto, Stopped-flow kinetic study of vitamin E regeneration reaction with biological hydroquinones (reduced forms of ubiquinone, vitamin K, and tocopherolquinone) in solution, J. Biol. Chem. 267 (1992), 22 277-22 281.
102. K. Mukai, H. Morimoto, S. Kikuchi and S. Nagaoka, Kinetic study of free-radical-scavenging action of biological hydroquinones (reduced forms of ubiquinone, vitamin K and tocopherol quinone) in solution, Biochim. Biophys. Acta 1157 (1993), 313-317.
103. A. Kontush, S. Meyer, B. Finckh, A. Kohlschütter and U. Beisiegel, α-Tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation, J. Biol. Chem. 271 (1996), 11 106-11 112.
104. G.R. Buettner, The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate, Arch. Biochem. Biophys. 300 (1993), 535-543.
105. D.A. Stoyanovsky, A.N. Osipov, P.J. Quinn and V.E. Kagan, Ubiquinone-dependent recycling of vitamin E radicals by superoxide, Arch. Biochem. Biophys. 323 (1995), 343-351.
106. B. Frei, M. Kim and B.N. Ames, Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations, Proc. Natl. Acad. Sci. USA 87 (1990), 4879-4883.
107. T. Takahashi, T. Yamaguchi, M. Shitashige, T. Okamoto and T. Kishi, Reduction of ubiquinone in membrane lipids by rat liver cytosol and its involvement in the cellular defence system against lipid peroxidation, Biochem. J. 309 (1995), 883-890.
108. R.E. Beyer, J. Segura-Aguilar, S. Di Bernardo, M. Cavazzoni, R. Fato, D. Fiorentini, M.C. Galli, M. Setti, L. Landi and G. Lenaz, The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems, Proc. Natl. Acad. Sci. USA 93 (1996), 2528-2532.
109. J. Cleary, D. Mohr, M.R. Adams, D.S. Celermajer and R. Stocker, Plasma and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and healthy controls, Free Radic. Res. 26 (1997), 175-182.
110. J. Lagendijk, J.B. Ubbink, R. Delport, W.J. Vermaak and J. A. Human, Ubiquinol/ubiquinone ratio as marker of oxidative stress in coronary artery disease, Res. Commun. Mol. Pathol. Pharmacol. 95 (1997), 11-20.
111. A. Kontush, A. Reich, K. Baum, T. Spranger, B. Finckh, A. Kohlschütter and U. Beisiegel, Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia, Atherosclerosis 129 (1997), 119-126.
112. C. Suarna, R.T. Dean, J. May and R. Stocker, Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate, Arterioscler. Thromb. Vasc. Biol. 15 (1995), 1616-1624.
113. X. Niu, V. Zammit, J.M. Upston, R.T. Dean and R. Stocker, Co-existence of oxidized lipids and α-tocopherol in lipoprotein fractions isolated from advanced human atherosclerotic plaques, Arterioscler. Thromb. Vasc. Biol. (1999) (in press).